POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE

Objective. To identify the possibility of multiparametrical magnetic resonance imaging (mpMRI) in the diagnosis of clinical recurrence of prostate cancer, with the aim of optimizing salvage radiation therapy (SLT).Material and methods. In this prospective study, the results of 89 patients with marke...

Full description

Saved in:
Bibliographic Details
Main Authors: F. A. Kossov, P. V. Bulychkin, B. P. Olimov, V. O. Panov, S. I. Tkachev, Yu. V. Buydenok, N. L. Shimanovskiy, M. A. Shorikov, I. E. Tyurin, B. I. Dolgushin
Format: Article
Language:English
Published: Luchevaya Diagnostika, LLC 2018-05-01
Series:Вестник рентгенологии и радиологии
Subjects:
Online Access:https://www.russianradiology.ru/jour/article/view/331
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839612557252362240
author F. A. Kossov
P. V. Bulychkin
B. P. Olimov
V. O. Panov
S. I. Tkachev
Yu. V. Buydenok
N. L. Shimanovskiy
M. A. Shorikov
I. E. Tyurin
B. I. Dolgushin
author_facet F. A. Kossov
P. V. Bulychkin
B. P. Olimov
V. O. Panov
S. I. Tkachev
Yu. V. Buydenok
N. L. Shimanovskiy
M. A. Shorikov
I. E. Tyurin
B. I. Dolgushin
author_sort F. A. Kossov
collection DOAJ
description Objective. To identify the possibility of multiparametrical magnetic resonance imaging (mpMRI) in the diagnosis of clinical recurrence of prostate cancer, with the aim of optimizing salvage radiation therapy (SLT).Material and methods. In this prospective study, the results of 89 patients with marker relapse (PSA) of prostate cancer (PCa) after radical prostatectomy was examined. mpMRI of the pelvis was performed before the SLT and 6 months later. Separately, in 44 patients, the data of dynamic contrast enhancement (DCE) with different contrast agents (gadobutrol, gadodiamide and gadoversetamide) were analyzed.Results. According to the model of multiple linear regression, the area of the substrate of clinical recurrence is statistically significantly correlated with the PSA level (R=0.74, p<0.0008), regardless of the all type of DCE administered. The sensitivity of mpMRI in detection of clinical recurrence of PCa was 92%, specificity 81%, accuracy 88%, which was assessed by comparison with PSA level. The use of the hypofractive radiation dose to the area of clinical recurrence of PCa, detected with mpMRI, showed a more progressive drop of the marker (PSA), compared to the standard SLT scheme (McNemarre test, p<0.03). A statistically significant correlations (by the Mann–Whitney criterion with p<0.018) from the signal change in DCE after the injection of contrast agents (different types) and the substrate area.Conclusion. mpMRI has high sensitivity, specificity and accuracy to detecting the substrate of the clinical recurrence of PCa. The use of DCE for concentration of 1.0 mmol (gadobutrol) significantly increases the reliability of detecting clinical recurrence of PCa, especially when the substrate is found to small and ultrasmall sizes. The application of DCE with the contrast agents at the concentration of 1.0 mmol (gadobutrol) prior to initiation of SLT course, helps to plan the proposed radiation exposure zone, with the aim of providing the necessary for a complete resorption of the recurrent tumor, a high tumor dose of radiation to the clinical recurrence region.
format Article
id doaj-art-a16d28d2ceff476786e2c738f2b32b69
institution Matheson Library
issn 0042-4676
2619-0478
language English
publishDate 2018-05-01
publisher Luchevaya Diagnostika, LLC
record_format Article
series Вестник рентгенологии и радиологии
spelling doaj-art-a16d28d2ceff476786e2c738f2b32b692025-07-28T07:00:57ZengLuchevaya Diagnostika, LLCВестник рентгенологии и радиологии0042-46762619-04782018-05-019929110010.20862/0042-4676-2018-99-2-91-100227POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCEF. A. Kossov0P. V. Bulychkin1B. P. Olimov2V. O. Panov3S. I. Tkachev4Yu. V. Buydenok5N. L. Shimanovskiy6M. A. Shorikov7I. E. Tyurin8B. I. Dolgushin9Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation.N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation.Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation.Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation.N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation.N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation.Pirogov Russian National Research Medical University.N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation.Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation.N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation.Objective. To identify the possibility of multiparametrical magnetic resonance imaging (mpMRI) in the diagnosis of clinical recurrence of prostate cancer, with the aim of optimizing salvage radiation therapy (SLT).Material and methods. In this prospective study, the results of 89 patients with marker relapse (PSA) of prostate cancer (PCa) after radical prostatectomy was examined. mpMRI of the pelvis was performed before the SLT and 6 months later. Separately, in 44 patients, the data of dynamic contrast enhancement (DCE) with different contrast agents (gadobutrol, gadodiamide and gadoversetamide) were analyzed.Results. According to the model of multiple linear regression, the area of the substrate of clinical recurrence is statistically significantly correlated with the PSA level (R=0.74, p<0.0008), regardless of the all type of DCE administered. The sensitivity of mpMRI in detection of clinical recurrence of PCa was 92%, specificity 81%, accuracy 88%, which was assessed by comparison with PSA level. The use of the hypofractive radiation dose to the area of clinical recurrence of PCa, detected with mpMRI, showed a more progressive drop of the marker (PSA), compared to the standard SLT scheme (McNemarre test, p<0.03). A statistically significant correlations (by the Mann–Whitney criterion with p<0.018) from the signal change in DCE after the injection of contrast agents (different types) and the substrate area.Conclusion. mpMRI has high sensitivity, specificity and accuracy to detecting the substrate of the clinical recurrence of PCa. The use of DCE for concentration of 1.0 mmol (gadobutrol) significantly increases the reliability of detecting clinical recurrence of PCa, especially when the substrate is found to small and ultrasmall sizes. The application of DCE with the contrast agents at the concentration of 1.0 mmol (gadobutrol) prior to initiation of SLT course, helps to plan the proposed radiation exposure zone, with the aim of providing the necessary for a complete resorption of the recurrent tumor, a high tumor dose of radiation to the clinical recurrence region.https://www.russianradiology.ru/jour/article/view/331prostate cancerprostatic specific antigenradiation therapyprostate cancer recurrencemultiparametric magnetic resonance imagingdynamic magnetic resonance imaging with contrast enhancementgadobutrol, gadodiamide, gadoversetamide
spellingShingle F. A. Kossov
P. V. Bulychkin
B. P. Olimov
V. O. Panov
S. I. Tkachev
Yu. V. Buydenok
N. L. Shimanovskiy
M. A. Shorikov
I. E. Tyurin
B. I. Dolgushin
POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
Вестник рентгенологии и радиологии
prostate cancer
prostatic specific antigen
radiation therapy
prostate cancer recurrence
multiparametric magnetic resonance imaging
dynamic magnetic resonance imaging with contrast enhancement
gadobutrol, gadodiamide, gadoversetamide
title POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
title_full POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
title_fullStr POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
title_full_unstemmed POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
title_short POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
title_sort possibilities of multiparametric magnetic resonance imaging in the personalization of salvage radiation therapy in patients with prostate cancer recurrence
topic prostate cancer
prostatic specific antigen
radiation therapy
prostate cancer recurrence
multiparametric magnetic resonance imaging
dynamic magnetic resonance imaging with contrast enhancement
gadobutrol, gadodiamide, gadoversetamide
url https://www.russianradiology.ru/jour/article/view/331
work_keys_str_mv AT fakossov possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT pvbulychkin possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT bpolimov possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT vopanov possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT sitkachev possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT yuvbuydenok possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT nlshimanovskiy possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT mashorikov possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT ietyurin possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence
AT bidolgushin possibilitiesofmultiparametricmagneticresonanceimaginginthepersonalizationofsalvageradiationtherapyinpatientswithprostatecancerrecurrence